Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIBROSTIM: Home-based tDCS vs Duloxetine for Fibromyalgia
NCT07203339Recruiting
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Sep 2025
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Randomised, double-blind trial in fibromyalgia (FM) (3 arms), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoints: Evaluation of Pain Interference at 12 months, Patient Global Impression of Improvement at Week 8 and 4 more. Started Sep 2025; status: recruiting.
02
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT07203339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07203339.